Genetics is a very broad field that deals with the study of heredity and changes in genes, which are passed on from parents to their offspring.
Each of us has a DNA that is like a huge library containing many books. Each such “book” is actually a gene , which contains genetic information with operating instructions that dictate what we look like, how our body works, and even some of our traits. Our DNA is made up of tens of thousands of genes.
Recent research shows that genetics play a role in the development of certain types of epilepsy.
If there is a genetic factor in the development of the disease in a particular person, this means that some of their genes have undergone changes (genetic mutations) that led to the improper functioning of proteins in brain cells.
The set of genes called the “genome” is like a giant instruction book containing all the information needed to build the human body. The information related to epilepsy is written in several chapters in this “book,” and each “chapter” is a gene that codes for a protein, which is created according to the instructions. If a “printing error” occurs in one of these “chapters” (genes), and as a result, the instructions are not given properly, this can lead to significant impairment in the function of the created protein, to the point of its complete loss.
The consequences of this may be – epilepsy.
As with many other chronic diseases, epilepsy is considered a condition in which there is more than one cause of the disease. Epilepsy can also occur under the influence of environmental factors such as: exposure to certain chemicals, brain trauma, infections, etc. In addition, the patient’s age and his underlying diseases are important. All of these factors are added to the genetic risk factor for epilepsy. In any case, it is not always possible to determine definitively why epilepsy develops in a particular person, and it is impossible to say that epilepsy is caused by a genetic factor alone; for example, there may be a situation in which there is a genetic predisposition to epilepsy, but the disease does not erupt because the conditions for its development are not ripe.
If the onset of epilepsy is at a young age, if it is severe, if there is a family history of the disease, and no clear environmental factor can be identified – the epilepsy in this case is suspected to be genetic.
Not necessarily. De novo mutations are new genetic changes that occur in the child, without being inherited from either parent. In such cases, there is no high risk in a future pregnancy – but it is important to consult a genetic counselor for full clarification.
In the past, everyone living with epilepsy received more or less the same treatment – depending solely on the type of seizures.
In recent years, thanks to advances in science, genetics, and gene sequencing technologies, we are better able to characterize the types of epilepsy – and sometimes even tailor unique treatment to an individual based on their genetic profile.
This field is called Precision Medicine – a therapeutic approach that takes into account the patient’s personal biological data: genetics, living environment, and lifestyle.
Although not everyone with epilepsy can currently be offered genetically tailored treatment, this option is becoming more available and widespread over the years.
When a genetic background to the disease is suspected, genetic testing for epilepsy is performed.
A genetic test is usually a simple blood test, which is sent to an advanced laboratory to examine a person’s genetic makeup.
The doctor will consider a referral for genetic testing in cases of:
A referral for genetic counseling can be obtained from a neurologist or pediatric neurologist.
The genetic counseling itself is received from a specialist geneticist, usually at a genetic institute located in a medical center.
The duration of genetic counseling is about an hour, more or less.
After genetic counseling, the sick boy or girl will receive a referral for blood tests.
These are blood tests that are done just like the regular blood tests we are all familiar with, but their purpose is different:
With their help, changes in genes can be identified, which may indicate a genetic factor in the development of the disease.
Genetic information is not always required to tailor precise treatment. Sometimes, based on clinical features, EEG, or brain imaging, it is possible to identify the active mechanism – and tailor a specific drug to it.
Examples:
Dravet Syndrome: Most often caused by a mutation in the SCN1A gene – which affects sodium channels in nerve cells. There are drugs, such as fenfluramine and stiripentol, that provide an example of non-gene-targeted therapy.
GLUT1 Deficiency: A problem with transporting glucose to the brain causes seizures and neurological problems. The treatment is not medication, but a ketogenic diet – which is based on fats as an alternative energy source for the brain.
Tuberous sclerosis complex (TSC): A genetic syndrome in which there is overactivity of the mTOR pathway. The drug everolimus inhibits the pathway – leading to improvement in seizures and other symptoms.
The SCN1A gene is a type of gene that gives instructions for creating a certain protein, which is very essential for the proper functioning of nerve cells, especially nerve cells in the brain. When there is a change in this gene (mutation), it can lead to a variety of neurological problems, such as Dravet syndrome – a severe epilepsy that begins in childhood. Children diagnosed with epilepsy can undergo genetic testing that will indicate that the genetic cause is SCN1A.
It is of great importance to detect a change in the SCN1A gene in genetic testing, because it is possible to receive specific drug treatment for this, upon the recommendation of the attending physician. The treatment is received from a pediatric neurologist, after he considers whether the treatment is indeed appropriate for the specific case.
In general, it would be wonderful if parents could be told before pregnancy if they were expecting a child with SCN1A. But the truth is that in most cases, the future parents don’t know they are at risk; it depends on the family history.
During pregnancy, proactive testing such as exome sequencing can be performed , unless there is a specific mutation known in the family, in which case it can be looked for specifically. In families where there is a known mutation, preimplantation diagnosis (through in vitro fertilization) can be offered.
Gene therapy is designed to repair, silence, or balance a defective gene.
Currently, studies and clinical trials are being conducted for gene therapy, including for genetic epilepsies, using:
These treatments are still in the development stages, but they open the door to a completely different therapeutic future.
In conclusion, personalized medicine is the cutting edge in epilepsy treatment:
As genetic and biological tools continue to evolve, so does our ability to tailor treatment in a more personalized, targeted, and effective manner.